Literature DB >> 7493667

Prevalence of anti-Toxoplasma gondii antibodies in the population of the area of Parma (Italy).

P P Valcavi1, A Natali, L Soliani, S Montali, G Dettori, C Cheezi.   

Abstract

Between 1987 and 1991, the prevalence of IgG antibodies to Toxoplasma gondii was determined by ELISA in 28,247 serum samples belonging to 19,432 subjects of the area of Parma (Italy). The overall prevalence was 48.5%. The correlation of infection with age, performed on 420 sera, showed a significant increase of positivity until 30-40 approximately years. In consecutive sera obtained from 172 subjects, the IgG and IgM production was analyzed for about 8 months, and four different patterns were delineated which were comprehensive of the wide range of immunological responses to Toxoplasma gondii exposure observed. Among pregnant females the prevalence of anti-Toxoplasma gondii antibodies was 48.7%, and 5 cases of seroconversion during the pregnancy were observed (0.27%) from which two cases of congenital toxoplasmosis originated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7493667     DOI: 10.1007/bf01719439

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  13 in total

1.  CONNATAL OCULAR TOXOPLASMOSIS.

Authors:  W A MANSCHOT; C B DAAMEN
Journal:  Arch Ophthalmol       Date:  1965-07

2.  Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987.

Authors:  M Forsgren; E Gille; I Ljungström; D J Nokes
Journal:  Lancet       Date:  1991-06-08       Impact factor: 79.321

Review 3.  AIDS commentary. Toxoplasmic encephalitis.

Authors:  B J Luft; J S Remington
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

4.  Prevalence of toxoplasma IgG among pregnant women in west London according to country of birth and ethnic group.

Authors:  R E Gilbert; P A Tookey; W D Cubitt; A E Ades; J Masters; C S Peckham
Journal:  BMJ       Date:  1993-01-16

5.  Prevalence of Toxoplasma gondii antibodies in the Chinese population of Hong Kong.

Authors:  R C Ko; F W Wong; D Todd; K C Lam
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

6.  Epidemiology of toxoplasmosis among pregnant women in the Paris area.

Authors:  D Jeannel; G Niel; D Costagliola; M Danis; B M Traore; M Gentilini
Journal:  Int J Epidemiol       Date:  1988-09       Impact factor: 7.196

7.  Prevalence of Toxoplasma gondii antibodies among children and teenagers in Italy.

Authors:  M E Moschen; T Stroffolini; S Arista; D Pistoia; A Giammanco; A Azara; D De Mattia; M Chiaramonte; G Rigo; B Scarpa
Journal:  Microbiologica       Date:  1991-07

8.  Toxoplasmosis in heart and heart and lung transplant recipients.

Authors:  T G Wreghitt; M Hakim; J J Gray; A H Balfour; P G Stovin; S Stewart; J Scott; T A English; J Wallwork
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

9.  Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population.

Authors:  B J Luft; Y Naot; F G Araujo; E B Stinson; J S Remington
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391

10.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

View more
  10 in total

1.  Prevalence of antibodies to Toxoplasma gondii in the female population of the County of Split Dalmatia, Croatia.

Authors:  V Punda-Polić; M Tonkić; V Capkun
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Seroprevalence for toxoplasmosis in individuals living in north west Tuscany: access to Toxo-test in central Italy.

Authors:  B Pinto; B Castagna; R Mattei; R Bruzzi; L Chiumiento; R Cristofani; W Buffolano; F Bruschi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

Review 3.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

4.  Risk factors for Toxoplasma infection in a reproductive age female population in the area of Belgrade, Yugoslavia.

Authors:  B Bobić; I Jevremović; J Marinković; D Sibalić; O Djurković-Djaković
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

5.  Implementation of Screening for Toxoplasma gondii Infection in Pregnancy.

Authors:  Massimo De Paschale; Carlo Agrappi; Maria Teresa Manco; Teresa Cerulli; Pierangelo Clerici
Journal:  J Clin Med Res       Date:  2010-05-19

6.  Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017.

Authors:  Daniela Fanigliulo; Serena Marchi; Emanuele Montomoli; Claudia Maria Trombetta
Journal:  Parasite       Date:  2020-01-14       Impact factor: 3.000

7.  Research on demographic, clinical and paraclinical aspects in pregnant women infected with Toxoplasma gondii.

Authors:  Andrei Csep; Luminița Ligia Vaida; Bianca-Maria Negruțiu; Bianca Ioana Todor; Claudia Teodora Judea-Pusta; Camelia Buhaș; Cristian Sava
Journal:  Exp Ther Med       Date:  2021-12-07       Impact factor: 2.447

8.  Sero-prevalence of toxoplasmosis in pregnant mothers and new born infants in eastern province, saudi arabia.

Authors:  A A Al-Mulhim; A M Al-Qurashi
Journal:  J Family Community Med       Date:  2001-01

9.  A 4-year evaluation of toxoplasmosis seroprevalence in the general population and in women of reproductive age in central Italy.

Authors:  M Mosti; B Pinto; A Giromella; S Fabiani; R Cristofani; M Panichi; F Bruschi
Journal:  Epidemiol Infect       Date:  2012-12-11       Impact factor: 4.434

10.  Detection of Toxoplasma gondii in Cord Blood Samples from Neonates in Tehran, Iran.

Authors:  Moloud Nahvi; Saeedeh Shojaee; Hossein Keshavarz; Mahboobeh Salimi; Mehdi Mohebali
Journal:  Iran J Public Health       Date:  2019-05       Impact factor: 1.429

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.